Elevance Health Long-Term Debt decreased by 0.1% to $30.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $28.11B to $30.77B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows an upward trend with a 9.8% CAGR.
An increase indicates higher financial leverage, which can amplify returns on equity but also increases interest expense and financial risk.
Loans and financial obligations with a maturity period exceeding one year, typically consisting of corporate bonds and n...
Capital-intensive firms or those with aggressive share buyback programs often carry higher long-term debt than asset-light competitors.
long_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.22B | $21.76B | $21.16B | $19.88B | $21.17B | $21.26B | $22.35B | $25.20B | $24.86B | $24.05B | $23.25B | $21.98B | $24.56B | $24.69B | $29.22B | $28.11B | $28.18B | $31.17B | $30.80B | $30.77B |
| QoQ Change | — | -2.1% | -2.8% | -6.0% | +6.4% | +0.4% | +5.1% | +12.8% | -1.4% | -3.3% | -3.3% | -5.5% | +11.8% | +0.5% | +18.3% | -3.8% | +0.2% | +10.6% | -1.2% | -0.1% |
| YoY Change | — | — | — | — | -4.7% | -2.3% | +5.6% | +26.7% | +17.5% | +13.1% | +4.0% | -12.8% | -1.2% | +2.7% | +25.7% | +27.9% | +14.7% | +26.3% | +5.4% | +9.5% |